Text Size

The Effect of Lifestyle Intervention Versus Gastric Bypass on Various Comorbidities in Morbidly Obese Subjects

This study has been completed.
Sponsor:
Collaborator:
Health Region South-East
Information provided by:
The Hospital of Vestfold
ClinicalTrials.gov Identifier:
NCT00273104
First received: January 5, 2006
Last updated: January 28, 2009
Last verified: January 2009
History of Changes
  Purpose

This follow up study (>1 year) aims to compare the effects of lifestyle intervention and gastric by pass surgery on various comorbidities associated with morbid obesity.


Condition Intervention Phase
Obstructive Sleep Apnea
Diabetes Mellitus
Hypertension
 Procedure: Behavior
 Phase 3

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: The Effect of Lifestyle Intervention vs Gastric Bypass on Various Comorbidities

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by The Hospital of Vestfold:

Primary Outcome Measures:
  • Improvement of co-morbidities

Estimated Enrollment: 180
Study Start Date: December 2005
Estimated Study Completion Date: December 2009
Detailed Description:

Not addressed

  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Morbidly obese patients

Exclusion Criteria:

-

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00273104

Locations
Norway
Hospital in Vestfold
Tonsberg, Norway, 3117
Sponsors and Collaborators
The Hospital of Vestfold
Health Region South-East
Investigators
Principal Investigator: Jøran Hjelmesæth, MD PhD Hospital of Vestfold
  More Information

No publications provided by The Hospital of Vestfold

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Responsible Party: Health Region South-East
ClinicalTrials.gov Identifier: NCT00273104     History of Changes
Other Study ID Numbers: S-05175
Study First Received: January 5, 2006
Last Updated: January 28, 2009
Health Authority: Norway:National Committee for Medical and Health Research Ethics

Additional relevant MeSH terms:
Diabetes Mellitus
Hypertension
Sleep Apnea Syndromes
Sleep Apnea, Obstructive
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases
Vascular Diseases
 Cardiovascular Diseases
Apnea
Respiration Disorders
Respiratory Tract Diseases
Sleep Disorders, Intrinsic
Dyssomnias
Sleep Disorders
Nervous System Diseases

ClinicalTrials.gov processed this record on May 21, 2013